122P - Cell-free (cf)DNA analysis identifies PIK3CA/AKT1 mutations associated with greater PFS improvement from the addition of ipatasertib (IPAT) to paclitaxel (P) in triple-negative breast cancer (TNBC)
| Autor: | Wongchenko, M. 1, Dent, R. 2, Kim, S-B. 3, Saura, C. 4, Oliveira, M. 4, Baselga, J. 5, Kapp, A.V. 6, Chan, W.Y. 7, Singel, S.M. 7, Maslyar, D.J. 7, Gendreau, S. 1 |
|---|---|
| Zdroj: | In Annals of Oncology September 2017 28 Supplement 5:v33-v34 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|